Replies to post #188489 on Biotech Values

[DewDiligence]

TRIL selling $50M of common & preferred stock, plus a 15% underwriter’s option on the common-stock portion:

http://finance.yahoo.com/news/trillium-therapeutics-announces-proposed-public-200100868.html